VC firms
Edit

Nexus Life Science Partners

http://www.merlinnexus.com
Last activity: 01.09.2011
Active
Mentions
6

Mentions in press and media 6

DateTitleDescription
Sign up to seeSign up to seeSign up to see
Aug 12, 2011Investors blocking PFE’s $56M ICGN bid say firm’s value could be $165MTwo Icagen (NASDAQ:ICGN) institutional investors opposed to Pfizer‘s (NYSE:PFE) $56 million offer for the pain drug development company now say the company’s value should be nearly three times that amount. Merlin Nexus and New Leaf Venture ...
Jul 29, 2011Pfizer-Icagen deal faces problem: Merlin Nexus opposes pricePfizer’s (NYSE:PFE) $56 million bid to acquire Icagen (NASDAQ:ICGN) faces a big hurdle — two of Icagen’s largest shareholders. Merlin Nexus and New Leaf Venture Partners, two firms holding Icagen stock, submitted a July 28 letter to the Ica...
Pfizer-Icagen deal faces problem: Merlin Nexus opposes pricePfizer’s (NYSE:PFE) $56 million bid to acquire Icagen (NASDAQ:ICGN) faces a big hurdle — two of Icagen’s largest shareholders. Merlin Nexus and New Leaf Venture Partners, two firms holding Icagen stock, submitted a July 28 letter to the Ica...
Pfizer extends Icagen offer; remains just shy of shares needed for dealPfizer‘s (NYSE:PFE) $56 million offer for Icagen (NASDAQ:ICGN) has been extended one more day as the pharmaceutical giant remains just shy of the minimum shares needed to execute the acquisition. Unless there is another extension, Pfizer’s ...
Investors blocking PFE’s $56M ICGN bid say firm’s value could be $165MTwo Icagen (NASDAQ:ICGN) institutional investors opposed to Pfizer‘s (NYSE:PFE) $56 million offer for the pain drug development company now say the company’s value should be nearly three times that amount. Merlin Nexus and New Leaf Venture ...

Reviews 0

Sign up to leave a review

Sign up Log In

FAQ about Nexus Life Science Partners

What has the press written about Nexus Life Science Partners?

Parsers VC has collected 6 articles mentioning Nexus Life Science Partners, among them “Investors blocking PFE’s $56M ICGN bid say firm’s value could be $165M” (Aug 12, 2011) and “Pfizer-Icagen deal faces problem: Merlin Nexus opposes price” (Jul 29, 2011).

Is Nexus Life Science Partners still active?

Yes, Nexus Life Science Partners is active; its latest activity on Parsers VC dates from Sep 1, 2011.